The Scientific Review and Monitoring Committee (SRMC) provides the critical review of scientific merit, methodology and validity of statistical analyses of cancer-relevant studies prior to activation. The committee will ensure proper prioritization of studies and the ability to monitor all cancer-related studies for expected progress relating to accrual goals and performance standards.
The SRMC has the authority and charge to close any study not meeting the expected accrual goals or trials that have become obsolete by new advances in the field and therefore whose scientific rationale has become superseded by clinical practice. For a protocol to be reviewed by the SRMC, both the sponsoring Disease Site Group (DSG) and/or Research Program (RP) must provide endorsement.
Committee Decisions
Following discussion, the Committee votes to Approve, Approve with Stipulations, Table or Disapprove the protocol, meaning:
- Approved: Approved for opening to accrual contingent upon obtaining IRB approval and completion of all other protocol activation steps
- Approved with Stipulations: Study is approvable pending satisfactory responses to reviewer questions and concerns. The initial reviewers will review the PI response to stipulations, and the SRMC Chair or a Co-Chair will provide final approval.
- Tabled: Substantial issues are present and revisions and/or formal reconsideration by SRMC are required.
- Disapproved: The study is not approved for opening.
Important Documents
Contact
For information related to the SRMC, please contact the SRMC Administrative team at UFHCC-SRMC@ufl.edu.
Submission Deadlines for SRMC
The SRMC comprises two panels that each meet twice per month: the Biomedical Sciences Panel (BMSP) and the Cancer Control and Population Sciences Panel (CCPSP). The meetings are held virtually.
Frequently Asked Questions
SRMC BMSP Membership List
| name | role | specialty/expertise |
|---|---|---|
| Ryan M. Thomas, M.D. | Chair | GI Surgery and Microbiome Biorepository |
| Michael Weaver, Ph.D., R.N. | V-Chair | Population Sciences & Biostatistics |
| Randal Henderson, M.D., MBA | V-Chair | Radiation Oncology |
| Frederic Kaye, M.D. | V-Chair | Thoracic Oncology |
| Elias Sayour, M.D., Ph.D. | V-Chair | Pediatric NeuroOnc |
| Karen Daily, D.O. | Core | Breast Oncology |
| Coy Heldermon, M.D., Ph.D. | Core | Breast Oncology |
| Petr Starostik, M.D. | Core | Pathology & Genetics |
| John Hiemenz, M.D. | Core | Hematologic Malignancies |
| Joanne Lagmay, M.D. | Core | Pediatric Oncology |
| David DeRemer, Pharm.D. | Core | Pharmacodynamics & Drug Development |
| Ji-Hyun Lee, DrPH | Core | Biostatistics |
| Shu Wang, Ph.D. | Core | Biostatistics |
| Karen Miller, JD | Core | Patient Advocate |
| Nosha Farhadfar, M.D. | Core | Hematologic Malignancies |
| Zhanna Galochkina, MS | Core | Biostatistics |
| Aaron Franke, M.D. | Core | Thoracic |
| Bently Doonan, M.D. | Core | Cutaneous |
SRMC CCPSP Membership List
| name | role | specialty/expertise |
|---|---|---|
| Michael Weaver, Ph.D., R.N. | Chair | Population Sciences & Biostatistics |
| Janice Krieger, Ph.D. | Core | Patient Communications & Decision Making |
| Deidre Pereira, Ph.D. | Core | Psychosocial & Biobehavioral Interventions |
| Carmen Bylund, Ph.D., FACH | Core | Survivorship |
| Georges Khalil, Ph.D. | Core | Cancer Prevention, Health Communication |
| Yingwei Yao, Ph.D. | Core | Biostatistics |
| Yi Guo, Ph.D. | Core | Biostatistics, Social Media & Big Data |
| Karen Miller, JD | Core | Citizen Scientist |
| Latrina Massey, MPH | Core | Community Outreach and Engagement |